Steven M. Toler

915 total citations
17 papers, 526 citations indexed

About

Steven M. Toler is a scholar working on Molecular Biology, Ophthalmology and Genetics. According to data from OpenAlex, Steven M. Toler has authored 17 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Ophthalmology and 3 papers in Genetics. Recurrent topics in Steven M. Toler's work include Drug-Induced Ocular Toxicity (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Sexual function and dysfunction studies (2 papers). Steven M. Toler is often cited by papers focused on Drug-Induced Ocular Toxicity (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Sexual function and dysfunction studies (2 papers). Steven M. Toler collaborates with scholars based in United States, Sweden and Austria. Steven M. Toler's co-authors include Jennifer R. Berman, Jennifer Gill, Laura Berman, Scott Haughie, Dennis A. Noe, Amarnath Sharma, Jessica S. Beaver, David P. Walling, John M. Kane and W. Wolfgang Fleischhacker and has published in prestigious journals such as The Journal of Urology, Schizophrenia Bulletin and American Journal of Ophthalmology.

In The Last Decade

Steven M. Toler

17 papers receiving 507 citations

Peers

Steven M. Toler

PMH

EDM

ONCOL

OPHTH

Hideki Komatsu Japan

Junya Chen China

Cleber E. Teixeira Brazil

Roberto Colombo Italy

Wenwen Zhang China

John Lesnick United States

Donna Simcoe United States

James H. Allison United States

Lihong Zhao China

Yuan Qu China

Hideki Komatsu Japan

Steven M. Toler

129 ×0.7

PMH

275 ×1.6

10 ×0.1

EDM

86 ×1.0

ONCOL

29 ×0.6

OPHTH

Citations per year, relative to Steven M. Toler Steven M. Toler (= 1×) peers Hideki Komatsu

Countries citing papers authored by Steven M. Toler

Since Specialization

Citations

This map shows the geographic impact of Steven M. Toler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Toler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Toler more than expected).

Fields of papers citing papers by Steven M. Toler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Toler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Toler. The network helps show where Steven M. Toler may publish in the future.

Co-authorship network of co-authors of Steven M. Toler

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Toler. A scholar is included among the top collaborators of Steven M. Toler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Toler. Steven M. Toler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Collinson-Pautz, Matthew R., Éva Morschl, An Lu, et al.. (2018). Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches. Molecular Therapy — Oncolytics. 12. 124–137. 69 indexed citations

Walling, David P., Stephen R. Marder, John M. Kane, et al.. (2015). Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia. Schizophrenia Bulletin. 42(2). 335–343. 82 indexed citations

Chancellor, Michael B., Eboo Versi, Chris Dvergsten, & Steven M. Toler. (2015). Clinical Efficacy and Tolerability of the Nicotinic Channel Modulator Dexmecamylamine in Subjects with Overactive Bladder. The Journal of Urology. 194(5). 1329–1335. 1 indexed citations

Dalén, Per, et al.. (2014). Clinical Pharmacokinetics of the Nicotinic Channel Modulator Dexmecamylamine (TC-5214) in Subjects with Various Degrees of Renal Impairment. Clinical Drug Investigation. 34(7). 457–465. 2 indexed citations

Xu, Hongmei, Anja Henningsson, Raj Tummala, et al.. (2014). Population pharmacokinetics of TC‐5214, a nicotinic channel modulator, in phase I and II clinical studies. The Journal of Clinical Pharmacology. 54(6). 707–718. 5 indexed citations

Toler, Steven M., Daniel Yohannes, Patrick M. Lippiello, & Michael B. Chancellor. (2013). Anticholinergic therapy for overactive bladder: A nicotinic modality?. Medical Hypotheses. 81(3). 456–458. 2 indexed citations

Toler, Steven M.. (2009). Creatine Is an Ergogen for Anaerobic Exercise. Nutrition Reviews. 55(1). 21–23. 1 indexed citations

Toler, Steven M., Dennis A. Noe, & Amarnath Sharma. (2006). Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme. Neurosurgical FOCUS. 21(6). 1–4. 52 indexed citations

Toler, Steven M.. (2005). Invited Review: Fluphenazine Augments Retinal Oxidative Stress. Journal of Ocular Pharmacology and Therapeutics. 21(4). 259–265. 4 indexed citations

10.

Toler, Steven M.. (2005). The plasmodial apicoplast was retained under evolutionary selective pressure to assuage blood stage oxidative stress. Medical Hypotheses. 65(4). 683–690. 13 indexed citations

11.

Toler, Steven M. & Ignacio Rodríguez. (2004). Not All Sulfa Drugs Are Created Equal. Annals of Pharmacotherapy. 38(12). 2166–2167. 3 indexed citations

12.

Toler, Steven M.. (2004). Oxidative Stress Plays an Important Role in the Pathogenesis of Drug-Induced Retinopathy. Experimental Biology and Medicine. 229(7). 607–615. 53 indexed citations

13.

Berman, Jennifer R., et al.. (2003). Safety and Efficacy of Sildenafil Citrate for the Treatment of Female Sexual Arousal Disorder: A Double-Blind, Placebo Controlled Study. The Journal of Urology. 170(6). 2333–2338. 166 indexed citations

14.

Birch, David G., Steven M. Toler, William H. Swanson, Gary E. Fish, & Alan M. Laties. (2002). A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration. American Journal of Ophthalmology. 133(5). 665–672. 28 indexed citations

15.

Pan, Lydia C., Philip A. Carpino, Bruce A. Lefker, et al.. (2001). Preclinical Pharmacology of CP-424,391, an Orally Active Pyrazolidinone-Piperidine Growth Hormone Secretagogue. Endocrine. 14(1). 121–132. 33 indexed citations

16.

Nickerson, David F., David A. Tess, & Steven M. Toler. (1997). First-pass metabolism and biliary recirculation of droloxifene in the female Sprague- Dawley rat. Xenobiotica. 27(3). 257–264. 5 indexed citations

17.

Tess, David A., Roderic O. Cole, & Steven M. Toler. (1995). Sensitive method for the quantitation of droloxifene in plasma and serum by high-performance liquid chromatography employing fluorimetric detection. Journal of Chromatography B Biomedical Sciences and Applications. 674(2). 253–260. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact